A/Prof Peter Revill
Medical Scientist
Molecular Research and Development
Victorian Infectious Diseases Reference Laboratory
+61 3 9342 2604
peter.revill@mh.org.au
Research Activities
Pathogenesis of HBV in the setting of HIV co-infectionThe innate immune response to HBV infection
Role of Splicing in HBV pathogenesis
The role of microRNA in HBV pathogenesis
HBV evolution and bioinformatic analysis
HBV genotypes and disease progression
Techniques/Expertise
Cell culture, virus purification, electron microscopy, sequencing, bioinformatics, evolutionary analysis, fluorescent microscopy, bioanalyser, RNA/DNA isolation, northern/Southern/Western blotting, PCR/real-time PCR, ultradeep and pyromark pyrosequencing.In addition to HBV, I have expertise in the purification and analysis of a wide range of plant and fungal (myco) viruses, including geminviruses, potyviruses, rhabdoviruses, nanoviruses, badnaviruses and barnaviruses
Collaborations
NationalDamian Purcell
Chloe Thio (NIH)
Alex Thompson (St. Vincent's Hospital, Melbourne)
Peter Angus (Austin Hospital, Melbourne)
Winita Hardikar (Royal Children's Hospital, Melbourne)
Josh Davis (Menzies Institute, Darwin).
Prof Stephen Locarnini
A/Prof Kumar Visvanathan
Prof Stephen Kent
Prof Sharon Lewin
International:
Anna Kramvis, Patrick Arbuthnot (University of the Witwatersrand, Johannesberg, South Africa)
Sang Hoon Ahn (Yonsei Universtiy College of Medicine, Korea)
Zhenghong Yuan (Fudan University, Shanghai, China)
Disease Models
In vitro hepatocyte cell culture models for transfection and transduction of replication competent infectious HBV cDNAsFuture studies using primary hepatocyte and transgenic mouse models are envisaged
Other Lab Members
Post doctoral Scientist:Dr Julianne Bayliss
Senior Research Assistant:
Vitini (Tina) Sozzi
PhD Students:
Liz Bannister (Royal Childrens Hospital)
Giovana Farinon Bernardi (DMI, University of Melbourne)
